Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-005077

Options or other derivatives

  • Chief Scientific Officer acquired 56,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Zago Wagner M. · Chief Scientific Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-02-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +56,000 $22.60 2031-02-25 56,000 56,000 D
Loading xslF345X03/doc1.xml…